Mounjaro vs Ozempic — Which One Works Better? - The Weigh-In: What the Numbers Mean

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to basket failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Unfollow podcast failed

Mounjaro vs Ozempic — Which One Works Better? - The Weigh-In: What the Numbers Mean

Listen for free

View show details

About this listen

Ben Synth examines SURMOUNT-5 trial results comparing tirzepatide to semaglutide for weight loss. The head-to-head study of 751 adults revealed tirzepatide achieved 20.2% average weight loss versus semaglutide's 13.7% over 72 weeks, marking a landmark moment in obesity pharmacotherapy and establishing dual-mechanism superiority.

Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

This content was created in partnership and with the help of Artificial Intelligence AI

No reviews yet